U.S. FDA Postpones Celltrion's Remicade Biosimilar Review Meeting
February 27, 2015
Gareth MacDonald
BioPharma Reporter.com
Axinn Counsel Stacie Ropka was quoted in the online BioPharma Reporter article, "U.S. FDA Postpones Celltrion's Remicade Biosimilar Review Meeting."
Click here to access the article.